Sanofi: Sanofi Consumer Healthcare India Full Year 2024 Earnings: Misses Expectations

Sanofi Consumer Healthcare India ( NSE:SANOFICONR ) Full Year 2024 Results Key Financial Results Revenue: ₹7.25b (down 13% from FY 2023). Net income: ₹1.81b (down 27% from FY 2023). Profit margin: 25% (down from 30% in FY 2023). The decrease in margin was driven by lower revenue. EPS: ₹78.59 (down from ₹107 in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Sanofi Consumer Healthcare India Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 6.9%. Earnings per share (EPS) also missed analyst estimates by 8.3%. Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India. Performance of the Indian Pharmaceuticals industry. The company's shares are up 3.7% from a week ago. Risk Analysis You should learn about the 1 warning sign we've spotted with Sanofi Consumer Healthcare India . New: Manage All Your Stock Portfolios in One Place We've created the ultimate portfolio companion for stock investors, and it's free. • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. About NSEI:SANOFICONR Sanofi Consumer Healthcare India Operates as a fast-moving consumer healthcare company in India. Flawless balance sheet with reasonable growth potential. Market Insights Community Narratives